anti-Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Antikörper

AGGF1 encodes an angiogenic factor that promotes proliferation of endothelial cells. Zusätzlich bieten wir Ihnen AGGF1 Kits (19) und AGGF1 Proteine (9) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
AGGF1 310005  
AGGF1 55109 Q8N302
AGGF1 66549 Q7TN31
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-AGGF1 Antikörper auf antikoerper-online.de

Showing 10 out of 90 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Lieferzeit Preis Details
Rind (Kuh) Kaninchen Unkonjugiert WB WB Suggested Anti-AGGF1 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:1562500 Positive Control: 293T cell lysate AGGF1 is strongly supported by BioGPS gene expression data to be expressed in Human HEK293T cells 100 μL 2 bis 3 Tage
$289.00
Details
Meerschweinchen Kaninchen Unkonjugiert WB 100 μL 11 bis 14 Tage
$551.83
Details
Human Kaninchen Unkonjugiert IHC, WB ABIN6272953 at 1/100 staining Human Melanoma tissue by IHC-P. The sample was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The sample was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary. Western blot analysis of extracts of mouse liver tissue, using AGGF1 antibody. 100 μL 11 bis 12 Tage
$390.77
Details
Human Kaninchen Unkonjugiert IF, IP, WB Immunoprecipitation of AGGF1 transfected lysate using anti-AGGF1 MaxPab rabbit polyclonal antibody and Protein A Magnetic Bead , and immunoblotted with AGGF1 purified MaxPab mouse polyclonal antibody (B02P) . Western Blot analysis of AGGF1 expression in transfected 293T cell line by AGGF1 MaxPab polyclonal antibody.Lane 1: AGGF1 transfected lysate(80.9 KDa).Lane 2: Non-transfected lysate. 100 μL 11 bis 12 Tage
$425.71
Details
Human Kaninchen Unkonjugiert IF (p), IHC (p), WB Antigen: 0.2 µg/100 µL  Primary: Antiserum, 1:500, 1:1000, 1:2000, 1:4000, 1:8000, 1:16000, 1:32000;  Secondary: HRP conjugated Goat Anti-Rabbit IgG at 1: 5000;  TMB staining; Read the data in Microplate Reader by 450nm Lane 1: mouse lung lysates Lane 2: mouse intestine lysates probed with Anti VG5Q/AGGF1 Polyclonal Antibody, Unconjugated (ABIN722380) at 1:200 in 4 °C. Followed by conjugation to secondary antibody at 1:3000 90min in 37 °C. Predicted band 79kD. Observed band size: 79kD. 100 μL 3 bis 7 Tage
$317.90
Details
Human Kaninchen Unkonjugiert ICC, IHC, WB Used in DAB staining on fromalin fixed paraffin-embedded Intestine tissue 100 μg 13 bis 16 Tage
$384.00
Details
Human Kaninchen Unkonjugiert ICC, IHC, WB Used in DAB staining on fromalin fixed paraffin-embedded Intestine tissue 100 μg 15 bis 18 Tage
$386.00
Details
Maus Kaninchen Unkonjugiert ICC, IHC, WB DAB staining on IHC-P; Samples: Mouse Liver Tissue 100 μg 13 bis 16 Tage
$396.00
Details
Ratte Kaninchen Unkonjugiert ICC, IHC, WB Figure. Western Blot; Sample: Recombinant protein. Figure.DAB staining on IHC-P. Samples: Rat Tissue 100 μg 13 bis 16 Tage
$418.00
Details
Human Kaninchen Unkonjugiert WB Western blot analysis in ZR-75-1 cell line lysates (35ug/lane). 400 μL 2 bis 3 Tage
$515.63
Details

Am meisten referenzierte anti-AGGF1 Antikörper

  1. Polyclonal AGGF1 Primary Antibody für IHC (fro), WB - ABIN540792 : Tian, Kadaba, You, Liu, Timur, Yang, Chen, Szafranski, Rao, Wu, Housman, DiCorleto, Driscoll, Borrow, Wang: Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. in Nature 2004 (PubMed)

Weitere Antikörper gegen AGGF1 Interaktionspartner

Zebrafish Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Interaktionspartner

  1. Bmp-induced activation of beta-catenin through Aggf1 regulates caudal vein development by promoting the Nr2f2-dependent differentiation of venous endothelial cells and their survival.

  2. aggf1 is involved in differentiation of both hematopoietic and endothelial lineages and acts upstream of scl, fli1, and etsrp in specification of hemangioblasts

  3. Our study establishes AGGF1 as an angiogenic factor with an important role in the specification of vein identity and suggests that AGGF1-mediated AKT signaling is responsible for establishing venous cell fate

Human Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Interaktionspartner

  1. LncRNA OR3A4 participates in the angiogenesis of hepatocellular carcinoma through modulating AGGF1/akt/mTOR pathway

  2. Aggf1 has a role in regulating vascular injury.

  3. High expression of AGGF1 predicts poor prognosis in gastric cancer patients.

  4. AGGF1 gene polymorphism does not affect the risk of varicose veins of the legs in ethnic Russians.

  5. Overexpression of AGGF1 is correlated with angiogenesis in hepatocellular carcinoma.

  6. AGGF1 reduces myocardial apoptosis and inflammation and enhances angiogenesis, leading to decreased infarct size after I/R injury.

  7. results of this study indicate that hypoxia down-regulates expression of the AGGF1 protein, but not AGGF1 mRNA, by inducing expression of miR-27a

  8. AGGF1 potently attenuated TNF-alpha triggered NF-kappaB pathway, as indicated by the decreased promoter activity, nuclear distribution and phosphorylation of NF-kappaB p65 subunit as well as the increased protein level of IkappaBalpha.

  9. analysis of sphingolipid modulation of angiogenic factor expression in neuroblastoma

  10. results define VG5Q as an angiogenic factor, establish VG5Q as a susceptibility gene for Klippel-Trenaunay syndrome, and show that increased angiogenesis is a molecular pathogenic mechanism of KTS

  11. VG5Q, E133K is a mutation that causes Klippel-Trenaunay and other overgrowth syndromes.

  12. This review describes the somatic mutation for angiogenic factor VG5Q, which may be the cause of the multisystem disorder Klippel-Trenaunay syndrome.

  13. identified two tagSNPs, rs13155212 and rs7704267 that capture information for all common variants in AGGF1 as a candidate susceptibility gene for Klippel-Trenaunay syndrome

  14. Knockdown of GATA1 expression by siRNA reduced expression of AGGF1, and resulted in endothelial cell apoptosis and inhibition of vessel formation.

Mouse (Murine) Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Interaktionspartner

  1. Aggf1 over-expression blocks liver fibrosis and Hepatic stellate cells (HSCs) activation. Aggf1 interacts with SMAD7 to suppress TGF signaling. DNA methylation regulates liver fibrosis and HSC activation by targeting Aggf1.

  2. AGGF1 protein therapy is effective in blocking neointimal formation after vascular injury by regulating a novel AGGF1-MEK1/2-ERK1/2-Elk-myocardin-SRF/p27 signaling pathway.

  3. Together with recent identification of somatic mutations in p110a (encoded by PIK3CA), our data establish a potential mechanistic link between AGGF1 and PIK3CA, the two genes identified for Klippel-Trenaunay syndrome (KTS)

  4. Data indicate that angiogenic factor Aggf1+/- knockout (KO) mice show reduced autophagy, which was associated with inhibition of angiogenesis and larger infarct areas.

  5. Mechanistically, Aggf1 activated the expression of gluconeogenesis gene and skewed the insulin signaling pathway to induce insulin resistance. Taken together, our data suggest that Aggf1 plays a role in steatosis in vivo and as such may be a new target in the development of therapeutics solutions against steatosis.

  6. Sphingolipid modulation of angiogenic factor expression in neuroblastoma

AGGF1 Antigen-Profil

Protein Überblick

This gene encodes an angiogenic factor that promotes proliferation of endothelial cells. Mutations in this gene are associated with a susceptibility to Klippel-Trenaunay syndrome. Pseudogenes of this gene are found on chromosomes 3, 4, 10 and 16.

Genbezeichner und Symbole assoziert mit AGGF1

  • angiogenic factor with G patch and FHA domains 1 (Aggf1) Antikörper
  • angiogenic factor with G-patch and FHA domains 1 (AGGF1) Antikörper
  • angiogenic factor with G patch and FHA domains 1 (aggf1) Antikörper
  • angiogenic factor with G patch and FHA domains 1 (CC1G_06398) Antikörper
  • angiogenic factor with G-patch and FHA domains 1 (aggf1) Antikörper
  • angiogenic factor with G-patch and FHA domains 1 (Aggf1) Antikörper
  • 2010009L17Rik Antikörper
  • 2310029P06Rik Antikörper
  • AGGF1 Antikörper
  • AW112072 Antikörper
  • DKFZp459G1317 Antikörper
  • GPATC7 Antikörper
  • GPATCH7 Antikörper
  • HSU84971 Antikörper
  • HUS84971 Antikörper
  • im:7146636 Antikörper
  • LOC100037685 Antikörper
  • Peg3 Antikörper
  • RGD1310888 Antikörper
  • VG5Q Antikörper
  • zgc:152959 Antikörper

Bezeichner auf Proteinebene für AGGF1

angiogenic factor with G patch and FHA domains 1 , angiogenic factor VG5Q , G patch domain-containing protein 7 , vasculogenesis gene on 5q protein

GENE ID SPEZIES
310005 Rattus norvegicus
471508 Pan troglodytes
100037685 Ovis aries
479176 Canis lupus familiaris
559905 Danio rerio
707686 Macaca mulatta
6012856 Coprinopsis cinerea okayama7130
100073274 Equus caballus
100145680 Xenopus (Silurana) tropicalis
100172934 Pongo abelii
100483706 Ailuropoda melanoleuca
100565487 Anolis carolinensis
100585011 Nomascus leucogenys
55109 Homo sapiens
66549 Mus musculus
511650 Bos taurus
100520064 Sus scrofa
416364 Gallus gallus
100722136 Cavia porcellus
Ausgewählte Anbieter für anti-AGGF1 (AGGF1) Antikörper
Haben Sie etwas anderes gesucht?